InsiderTrades

Form 4 for DXC DXC Technology Co

Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-02 · accession 0001688568-22-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-06-03 2022-06-02 DXC SALVINO MICHAEL J Pres, CEO, Dir F - Tax $35.13 -50.0K 621.3K -7% -$1.76M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-02 F D 30,776 $35.13 590,490 D — — (F3) Shares withheld to satisfy tax liabilities arising from the vesting and settlement of 69,252 performance-vesting RSUs awarded on October 1, 2020 upon the consummation of the sale by DXC Technology Company of its U.S. State and Local Health and Human Services Business, that vested on June 2, 2022 in the last of three installments. (F2) Amount reported includes unvested RSUs.
2 Common Common Stock 2022-06-02 F D 19,251 $35.13 621,266 D — — (F1) Shares withheld to satisfy tax liabilities arising from the vesting and settlement of 43,318 restricted stock units (RSUs) that vested on June 2, 2022 in the second of three equal annual installments. (F2) Amount reported includes unvested RSUs.